KEGG   DRUG: D02994Help
Entry
D02994                      Drug                                   

Name
Rituximab (genetical recombination) (JAN);
Rituximab (USAN/INN);
Rituxan (TN)
Product
Activity
Antineoplastic [microtubule inhibitor];
Monoclonal antibody [DS:H00005 H00008 H00080]
Remark
Therapeutic category: 
ATC code: 
Comment
anti-CD20 monoclonal antibody
Target
CD20 [HSA:931] [KO:K06466]
  Pathway
hsa04640  Hematopoietic cell lineage  
 
Interaction
Genomic biomarker: CD20 [HSA:931]
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01X OTHER ANTINEOPLASTIC AGENTS
    L01XC Monoclonal antibodies
     L01XC02 Rituximab
      D02994  Rituximab (genetical recombination) (JAN); Rituximab (USAN/INN)
USP drug classification [BR:br08302]
 Antineoplastics
  Monoclonal Antibodies
   Rituximab
    D02994  Rituximab (genetical recombination) (JAN); Rituximab (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4291  Other Antitumors
     D02994  Rituximab (genetical recombination) (JAN); Rituximab (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Others
  Cellular antigens
   CD20
    Rituximab
     D02994  Rituximab (genetical recombination) (JAN); Rituximab (USAN/INN)
Antineoplastics [BR:br08308]
 Molecularly targeted agents
  Monoclonal antibody
   Rituximab
    D02994  Rituximab (genetical recombination) (JAN); Rituximab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
174722-31-7
PubChem: 
DrugBank: 
NIKKAJI: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system